Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 10.77M | 100% | $ 10.77M |
3/31/2025 | $ 19.96M | 100% | $ 19.96M |
12/31/2024 | $ 19.63M | 100% | $ 19.63M |
9/30/2024 | $ 20.27M | 100% | $ 20.27M |
6/30/2024 | $ 20.71M | 100% | $ 20.71M |
3/31/2024 | $ 15.07M | 100% | $ 15.07M |
12/31/2023 | $ 14.92M | 100% | $ 14.92M |
9/30/2023 | $ 10.63M | 100% | $ 10.63M |
6/30/2023 | $ 46.8M | 100% | $ 46.8M |
3/31/2023 | $ 43.24M | 100% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for CARISMA THERAPEUTICS INC is calculated as follows: GP [ $ 11.24M ] / Revenues [ $ 11.24M ]
(=) Gross % [ 100% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.11% |
median | 49.46% |
std | 31.58% |